Multicancer screening test based on the detection of circulating non haematological proliferating atypical cells.

ABSTRACT:

Background

the problem in early diagnosis of sporadic cancer is understanding the individual's risk to develop disease. In response to this need, global scientific research is focusing on developing predictive models based on non-invasive screening tests. A tentative solution to the problem may be a cancer screening blood-based test able to discover those cell requirements triggering subclinical and clinical onset latency, at the stage when the cell disorder, i.e. atypical epithelial hyperplasia, is still in a subclinical stage of proliferative dysregulation.

Methods

a well-established procedure to identify proliferating circulating tumor cells was deployed to measure the cell proliferation of circulating non-haematological cells which may suggest tumor pathology. Moreover,

SUBMITTER: Malara N 

PROVIDER: S-EPMC10863189 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature